These results are consistent with the proposed oncogenic role of GRHL2; loss of GRHL2 in the BC cell line MCF7 is associated with decreased proliferation and GRHL2 can also suppress the death receptors FAS and DR5 (refs. 78,79). This evidence concerns the gene FAS and breast cancer.